SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-263997
Filing Date
2020-10-05
Accepted
2020-10-05 17:18:01
Documents
13
Period of Report
2020-10-05
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39257d8k.htm   iXBRL 8-K 29605
2 EX-99.1 d39257dex991.htm EX-99.1 8503
  Complete submission text file 0001193125-20-263997.txt   165539

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20201005.xsd EX-101.SCH 3093
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20201005_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20201005_pre.xml EX-101.PRE 11423
6 EXTRACTED XBRL INSTANCE DOCUMENT d39257d8k_htm.xml XML 3339
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 201224498
SIC: 2834 Pharmaceutical Preparations